North America Diagnostic Radiopharmaceutical Market Outlook: Growth Opportunities in Nuclear Medicine Read More - https://www.theinsightpartners.com/reports/diagnostic-radiopharmaceutical-market The North America diagnostic radiopharmaceutical market is expected to remain a major contributor to the global industry through 2034, supported by the region’s advanced healthcare infrastructure, increasing adoption of molecular imaging, and growing demand for precise disease diagnosis. Diagnostic radiopharmaceuticals are increasingly used in positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to visualize physiological and biochemical processes inside the body.